Announced Tue, 9 Sept · 20:27 IST

Annual General Meeting - Voting Results

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shree Ganesh Remedies held its 30th Annual General Meeting on September 9, 2025 via video conferencing, where all five resolutions were passed with overwhelming shareholder approval. The resolutions covered: adoption of the audited standalone and consolidated financial statements for FY25, re-appointment of Mr. Parth Chandulal Kothia (DIN: 08830608) as a director retiring by rotation, appointment of M/s. Prachi Bansal & Associates as Secretarial Auditors for a five-year term, ratification of the Cost Auditors' remuneration, and appointment of Ms. Shruti Sohane (DIN: 10899663) as an Independent Director (passed as a Special Resolution). Approximately 74.23% of total shares (95.29 lakh out of 128.38 lakh) participated in voting, with promoters (holding 93.46 lakh shares) voting 99.89% of their holding in favor. All resolutions received between 99.98% and 100% support, with negligible dissent (only 501–1,653 votes against).

Likely market impact

This is a routine, cleanly passed AGM with near-unanimous shareholder approval on all items, including the addition of a new independent director. No governance concerns or negative signals emerge from these results; the stock is unlikely to see any material reaction to this filing.